Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.05

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.05

Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results

March 7, 2017 4:15 PM EST

NASHVILLE, Tenn., March 7, 2017 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced fourth quarter and full year 2016 financial results. Net Revenues for the year ended December 31, 2016 were $33.0 million with Adjusted Earnings of $1.8 million or $0.11 per share.

As of December 31, 2016, the Company had approximately $93.4 million in total assets including approximately $50.1 million in cash and investments. Total Liabilities were $20.3 million and Total Shareholder's Equity was $73.2 million. Cumberland also had approximately... More